DKK1 and melanoma: Our lab and others have also demonstrated that DKK1 drives the accumulation of suppressive myeloid populations in melanoma, lung carcinoma, prostate cancer and gastric cancer18, 23, 24, 25, 26, 27, ultimately reducing anti-tumor T cell and NK cell responses.